Inhibition of ERK attenuates force development by lowering myosin light chain phosphorylation
- 1 February 2002
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 282 (2) , H602-H610
- https://doi.org/10.1152/ajpheart.00221.2001
Abstract
Phosphorylation of the actin-associated protein caldesmon (CaD) by extracellular signal-regulated kinases (ERK1/2) is purported to participate in force maintenance by vascular smooth muscle. We examined the interrelationship among ERK1/2 activity, phosphorylation of the high molecular weight isoform of CaD (h-CaD) and the 20-kDa myosin light chain (LC20), and isometric force in strips of porcine carotid artery stimulated with endothelin-1 (ET-1; 50 nM). After an initial delay, ERK1/2 activity increased in parallel with ET-1-mediated force; h-CaD phosphorylation increased modestly. 2-(2′-Amino-3′-methoxyphenyl)-ox-anaphthalen-4-one (PD-098059; 50 μM), an ERK1/2 kinase inhibitor, significantly reduced basal ERK1/2 activity within 1 h, but only partially attenuated h-CaD phosphorylation at 3 h. The mechanisms underlying the temporal dissociation of ERK1/2 activity from h-CaD phosphorylation are unknown, but include the possibility that a kinase other than ERK1/2 phosphorylates h-CaD or, more likely, that phosphate turnover in h-CaD is very slow. PD-098059 partially inhibited the development of ET-1-stimulated force only in Ca2+-replete physiological saline solution, primarily by reducing LC20phosphorylation, yet had no effect on myosin light chain kinase in vitro. These inhibitory effects were most evident during the early phase of force production. The inhibitory effect of PD-098059 on force could not be correlated with a corresponding effect on ERK1/2-mediated h-CaD phosphorylation because force in arterial strips stimulated with ET-1 in the absence or presence of PD-098059 tended to approximate each other over time despite significant differences in the level of h-CaD phosphorylation. Force and LC20phosphorylation in response to KCl depolarization were unaffected by PD-098059. These results show that ERK1/2 may regulate force in arterial smooth muscle, but suggest that the mechanism for this effect is by inhibiting LC20phosphorylation.Keywords
This publication has 18 references indexed in Scilit:
- Mammal-specific, ERK-dependent, Caldesmon Phosphorylation in Smooth MuscleJournal of Biological Chemistry, 1999
- Phosphorylation and activation of smooth muscle myosin light chain kinase by MAP kinase and cyclin-dependent kinase-1Biochemistry and Cell Biology, 1996
- Phosphorylation by MAPKAP Kinase 2 Activates Mg2+-ATPase Activity of Myosin IIBiochemical and Biophysical Research Communications, 1996
- Activation of Mitogen-Activated Protein Kinase in Porcine Carotid ArteriesCirculation Research, 1995
- Identification of mitogen‐activated protein kinase phosphorylation sequences in mammalian h‐CaldesmonFEBS Letters, 1993
- Phosphorylation sequences in h‐caldesmon from phorbol ester‐stimulated canine aortasFEBS Letters, 1992
- Phosphorylation of high‐Mr caldesmon by protein kinase C modulates the regulatory function of this protein on the interaction between actin and myosinEuropean Journal of Biochemistry, 1990
- Phosphorylation of myosin light chain kinase from vascular smooth muscle by cAMP- and cGMP-dependent protein kinasesJournal of Molecular and Cellular Cardiology, 1985
- The Function of Myosin and Myosin Light Chain Kinase Phosphorylation in Smooth MuscleAnnual Review of Pharmacology and Toxicology, 1985
- Conformational transition accompanying the binding of calcium(2+) ion to the protein activator of 3',5'-cyclic adenosine monophosphate phosphodiesteraseBiochemistry, 1977